Cormorant Asset Management, LP
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 1583977
BOSTON, MA
Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$214,265,600
-$71,033,645 QoQ
Shares Held
640,000
-27.7% QoQ
Ownership
2.29%
of shares outstanding
% of Portfolio
10.88%
of 13F equity value
Holder Rank
#16
of 306 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. PRAX ranks #1 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
This page
|
640,000 | $214,265,600 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $136,234,886 | |
| 3 | PBLS |
Parabilis Medicines, Inc.
|
4,615,612 | $126,329,300 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
2,657,521 | $110,738,900 | |
| 5 | ERAS |
Erasca, Inc.
|
6,000,000 | $109,920,000 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
2,510,000 | $101,981,300 | |
| 7 | EYPT |
EyePoint, Inc.
|
7,000,000 | $100,100,000 | |
| 8 | ALMS |
Alumis Inc.
|
3,285,596 | $92,456,671 |
All Filings in PRAX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,265,600 | 640,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $285,299,245 | 885,500 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $280,003,000 | 950,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $53,000,000 | 1,000,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $68,331,250 | 1,625,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $66,083,150 | 1,745,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $130,310,134 | 1,693,219 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $130,310,134 | 1,693,219 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $50,059,800 | 870,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $28,331,600 | 685,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $79,936,200 | 1,310,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $14,110,926 | 633,345 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $16,245,000 | 9,500,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,925,000 | 9,500,000 | Shares | Defined | 2023-08-14 | |
| 2022-03-31 | $7,682,065 | 752,406 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,822,398 | 752,406 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,936,736 | 1,024,161 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,721,370 | 1,024,145 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $35,188,990 | 1,074,145 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $59,099,457 | 1,074,145 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||